TG THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
TG THERAPEUTICS, INC. (TGTX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $595.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-27
- TG THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-03-31 was $595.00K.
- TG THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $595.00K.
- TG THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $2.19M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2023-12-31 | $595.00K 10-K · filed 2026-02-27 | |
| 2023-03-31 | $595.00K 10-Q · filed 2024-11-07 | |
| 2021-12-31 | $2.19M 10-K · filed 2024-02-29 | |
| 2007-12-31 | $83.67K 10-Q · filed 2011-11-14 | |
| 2004-12-31 | $4.59K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |